Instrument Inactif

Communiqués Horizon Pharma Inc Nasdaq

Actions

US44047T1097

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

16/01	Santé Canada approuve UPLIZNA® (inebilizumab pour injection) d'Horizon Therapeutics plc pour le traitement des troubles du spectre de la neuromyélite optique	CI
2023	Amgen : en hausse, un analyste relève son objectif	CF

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC	09/10/23	AQ
Rule 17(d) Announcement, Horizon Therapeutics plc	06/10/23	AQ
Rule 17(e) Announcement - Horizon Therapeutics plc	06/10/23	BU
Rule 17(d) Announcement – Horizon Therapeutics plc	05/10/23	BU
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	03/10/23	BU
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	03/10/23	BU
Horizon Therapeutics plc Announces New UPLIZNA Data in Neuromyelitis Optica Spectrum Disorder to be presented at ECTRIMS 2023	03/10/23	AQ
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	02/10/23	BU
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	02/10/23	BU
Horizon Therapeutics - New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA to Support Thyroid Eye Disease Patient Outcomes	02/10/23	AQ
Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023	02/10/23	BU
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	29/09/23	BU
New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes	29/09/23	BU
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	27/09/23	BU
Horizon Therapeutics plc Named to U.S. News & World Report's 2024 List of Best Companies to Work For in the Health Care Industry	27/09/23	AQ
Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry	26/09/23	BU
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	25/09/23	BU
Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List	19/09/23	BU
Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata	13/09/23	BU
FTC, States Agree On Path Forward For Amgen's Horizon Therapeutics Deal	11/09/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Horizon Pharma Inc Nasdaq

Actions

US44047T1097

Communiqués

Filtres